Takeda Pharmaceutical Co Ltd
TSE:4502
Takeda Pharmaceutical Co Ltd
TSE:4502
Price:
4 143 JPY
-0.24%
Market Closed
Updated:
May 2, 2024
EV/IC
Enterprise Value to IC
Enterprise Value to IC
0.8
Current
0.8
Median
1.9
Industry
Higher
than median
Lower
than industry value
Enterprise Value to Invested Capital (EV/IC) ratio is a valuation multiple that measures the dollars in Enterprise Value for each dollar of capital invested by shareholders and lenders.
EV/IC
=0.8
Enterprise Value
/
10.5T
Invested Capital
13.4T
All Countries
| Market Cap | EV/IC | ||||
|---|---|---|---|---|---|
| JP |
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
6.5T JPY | 0.8 | |
| JP |
N
|
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
|
776 550.9T JPY | 4 032 690.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
737.4B USD | 12.9 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
4T DKK | 15.4 | |
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 326.4 | |
| JP |
|
Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
|
82T JPY | 113.1 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
363.9B USD | 2.7 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
326.1B USD | 3.7 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
188.7B GBP | 27.7 | |
| CH |
|
Novartis AG
SIX:NOVN
|
182B CHF | 2.5 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
175.9B CHF | 2.5 |
EV/IC Forward Multiples
Forward EV/IC multiple is a version of the EV/IC ratio that uses forecasted invested capital for the EV/IC calculation. 1-Year, 2-Years, and 3-Years forwards use invested capital forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/IC
N/A
2-Years Forward
EV/IC
N/A
3-Years Forward
EV/IC
N/A
You don't have any saved screeners yet
